Juno Therapeutics
Industry / private company
Location:
Göttingen,
Germany (DE)
ROR: https://ror.org/01zv88x17
A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity (2020)
Roex MCJ, Hageman L, Veld SAJ, Van Egmond E, Hoogstraten C, Stemberger C, Germeroth L, et al.
Journal article
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study (2020)
Roex MCJ, Van Balen P, Germeroth L, Hageman L, Van Egmond E, Veld SAJ, Hoogstraten C, et al.
Journal article
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function (2019)
Schober K, Mueller TR, Goekmen F, Grassmann S, Effenberger M, Poltorak M, Stemberger C, et al.
Journal article, Original article